Industry news

• The TsRPT has simplified the issuance of labeling codes for vital medicines

  16 September 2021 GxPnews

  The drug labeling system has started to automatically identify vital drugs and medicines worth less than 20 rubles that are issued marking codes for free, TASS reports with reference to the press service of the Center for the Development of Advanced Technologies (TsRPT), which is the operator of the labeling system.

• 3D printing – current pharmaceutical applications and future directions

  15 September 2021 Hannah Balfour / European Pharmaceutical Review

  3D printing has the potential to revolutionise the pharmaceutical manufacturing industry; however, few 3D-printed products have been approved since the first in 2015. In this article, EPR’s Hannah Balfour explores the technologies currently being evaluated for use in the 3D printing of pharmaceuticals, and the work of key market players to develop and advance their applications from research to commercial.

• How pharma can partner with influencers to build trust

  15 September 2021 FiercePharma

  When a person is faced with a new diagnosis, they turn to the individuals they trust most – their physician, friends, family and other patients. Yet, it’s not always easy to find other people who have the same condition and can truly relate. So where do patients turn and how can pharma get engaged?

• Embedding inclusion in pharmaceutical design

  14 September 2021 Raafi-Karim Alidina / European Pharmaceutical Review

  In this article, Included’s Raafi-Karim Alidina explores biases in product design, outlining how they impact pharmaceuticals as well as technologies, and practical steps to enhance diversity and ensure inclusion.

• The Ministry of Health will purchase medicines for HIV patients for 1.4 billion rubles in 2022

  14 September 2021 GxPnews

  The Russian Ministry of Health has announced three tenders for the purchase of antiretroviral drugs, which will be funded from the public budget for 2022, Kommersant reports. This is indicated in tender documents posted on the public procurement portal.

• EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty

  13 September 2021 PharmProm.Ru

  EMA has started evaluating an application for the use of a booster dose of Comirnaty to be given 6 months after the second dose in people aged 16 years and older. Booster doses are given to vaccinated people (i.e. people who have completed their primary vaccination) to restore protection after it has waned.

• Russian scientists developed intestinal soluble capsules

  13 September 2021 PharmProm.Ru

  Crohn’s disease and ulcerative colitis are severe chronic bowel diseases for which there are no effective drugs yet. The main approach in their therapy is to take drugs that reduce inflammation and restore the intestinal mucosa. At the same time, there are still no funds on the market that can gradually release an active substance inside the body, which could significantly increase the effectiveness of therapy. Under the leadership of the Federal State Budgetary Institution “CSP” of the FMBA of Russia, scientists from the N.N. DI Mendeleev developed a technology for obtaining such a dosage form: they created enteric capsules containing a biopolymer complex that releases an active substance at a controlled rate, which ensures a prolonged action and high bioavailability of the drug.

• The single-component Sputnik Light vaccine authorized in Armenia

  10 September 2021 PharmProm.Ru

  The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health of the Republic of Armenia.

• Capsules for the treatment of Crohn’s disease and ulcerative colitis have been created in Russia

  10 September 2021 GxPnews

  Specialists of the Russian University of Chemical Technology named after D.I Mendeleev, under the leadership of the Federal State Budgetary Institution “TsSP” of the FMBA of Russia, developed intestinal soluble capsules of prolonged action to treat chronic intestinal diseases.

• The Cabinet of Ministers will allocate 2 billion rubles to combating the spread of COVID-19

  09 September 2021 GxPnews

  The government will allocate 2 billion rubles from its reserve fund to combat the spread of COVID-19 and other infections. The corresponding order was signed by Mikhail Mishustin, the head of the Russian Cabinet of Ministers.